PMI Stock Summary and Trading Ideas (Picard Medical | AMEX:PMI)

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.

Picard Medical trades on the AMEX stock market under the symbol PMI.

As of October 22, 2026, PMI stock price declined to $7.37 with 245,268 million shares trading.

PMI has a beta of -2.48, meaning it tends to be less sensitive to market movements. PMI has a correlation of 0.02 to the broad based SPY ETF.

PMI has a market cap of $15.14 million. This is considered a Sub-Micro Cap stock.

Last quarter Picard Medical reported $3 million in Revenue and -$1.33 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.17.

The top ETF exchange traded funds that PMI belongs to (by Net Assets): VTI.

PMI has underperformed the market in the last year with a price return of -98.8% while the SPY ETF gained +14.8%. However, in the short term, PMI had mixed performance relative to the market. It has outperformed in the last 3 months, returning +22.3% vs +2.3% return in SPY. But in the last 2 weeks, PMI shares have been beat by the market, returning -21.3% compared to an SPY return of -1.8%.

PMI support price is $7.85 and resistance is $11.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PMI shares will trade within this expected range on the day.